Inventor · disambiguated record
F. Christopher Zusi
Also filed as: ZUSI F CHRISTOPHER
15 granted patents·7 pending applications·135 citations·filing 1979–2015
92Inventor score
Files withBRISTOL MYERS SQUIBB CO13COOK II JAMES H3MCDONALD IVAR M2WESTWOOD PHARMACEUTICALS INC2EASTMAN KODAK CO1
Top patents by PatentIndex Score
22 records- 0191US7863291B2Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 4, 2011·22 cites·14 claims
- 0287US8309577B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsCOOK II JAMES H·Filed 2009·Granted Nov 13, 2012·10 cites·18 claims
- 0384US5086060ACompound and method for treating skin for acne or psoriasisEASTMAN KODAK CO·Filed 1990·Granted Feb 4, 1992·30 cites·16 claims
- 0481US7456194B2Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 25, 2008·5 cites·6 claims
- 0580US9708323B2Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 18, 2017·2 cites·12 claims
- 0676US8507516B2Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Aug 13, 2013·4 cites·3 claims
- 0775US8278320B2Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Oct 2, 2012·4 cites·14 claims
- 0874US8481555B2Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugsLENTZ KIMBERLEY A·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 0971US5202350AFuranone anti-inflammatory agentsBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Apr 13, 1993·13 cites·19 claims
- 1069US9738642B2Triazolopyridine ether derivatives and their use in neurological and pyschiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·11 claims
- 1166US2015094309A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1265US2014221377A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1362US2013131064A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1461US5164406AMethod for enhancing transdermal penetration and compositions useful thereinBRISTOL MYERS SQUIBB CO·Filed 1989·Granted Nov 17, 1992·30 cites·19 claims
- 1559US2016101104A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1658US2015342935A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1756US2012035178A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1856US2012035189A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1953US4282206AMethod of protecting human skin from ultraviolet radiationWESTWOOD PHARMACEUTICALS INC·Filed 1979·Granted Aug 4, 1981·8 cites·2 claims
- 2046US10174052B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 8, 2019·0 cites·13 claims
- 2146US7601751B2Indole acetic acid acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 13, 2009·0 cites·6 claims
- 2231US4375545AProcess for the synthesis of the nicotinyl ester of 6-aminonicotinic acidWESTWOOD PHARMACEUTICALS INC·Filed 1981·Granted Mar 1, 1983·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when F. Christopher Zusi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →